Gastar Exploration and 12 Stocks Making Deal Buzz This Week

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Here’s your Cheat Sheet to this week’s top mergers and acquisition news:

Anadarko Petroleum Corp. (NYSE:APC): Current price $91.31

Anadarko said Monday it will divest a 10 percent interest in Mozambique’s Offshore Area 1 to ONGC Videsh Ltd., a wholly owned subsidiary of Oil and Natural Gas Corporation Ltd., for $2.64 billion in cash. Anadarko will stay the operator of Area 1 with a working interest of 26.5 percent. The transaction should close around the end of the year.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

APC 20130901

AstraZeneca Group (NYSE:AZN): Current price $49.21

AstraZeneca said Monday that its global biologics research and development unit, MedImmune, will purchase privately held biologics firm Amplimmune, which is centered on developing novel therapeutics in cancer immunology. The deal should reinforce MedImmune’s oncology pipeline by obtaining multiple early stage assets for its immune-mediated cancer therapy portfolio including AMP-514, according to a press release.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

AZN 20130901

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business